Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neurodevelopmental Abnormality clinical trials
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Neurodevelopmental Abnormality: 3 US clinical trials tracked, none currently recruiting.
Neurodevelopmental Abnormality is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is NICHD Global Network for Women's and Children's Health, running 1 of these trials.
Enrollment posture brief
Registry condition neurodevelopmental-abnormality
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Neurodevelopmental Abnormality has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neurodevelopmental Abnormality on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neurodevelopmental Abnormality is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Nationwide Children's Hospital
NCT03782610
Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)
Sharp HealthCare
NCT03621943
ASPIRIN: Neurodevelopmental Follow-up Trial
NICHD Global Network for Women's and Children's Health
NCT04888377
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Neurodevelopmental Abnormality records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neurodevelopmental Abnormality trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neurodevelopmental Abnormality page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Neurodevelopmental Abnormality trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- NICHD Global Network for Women's and Children's Health sponsors the most Neurodevelopmental Abnormality trials on record, review their full trial history before evaluating a specific study. See NICHD Global Network for Women's and Children's Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurodevelopmental Abnormality condition card totals 3 registered trials; most-linked intervention Early Cord Clamping; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.